“VEMURAFENIB AS A SELECTIVE INHIBITOR OF THE SERINE THREONINE-PROTEIN KINASE B-RAF, USED IN THE TREATMENT OF MELANOMA”. Prospects in Pharmaceutical Sciences, vol. 14, no. 8, Dec. 2016, pp. 52-56, https://doi.org/10.56782/pps.117.